TLR expression in human melanoma cells

被引:22
作者
Saint-Jean, Melanie [1 ,2 ]
Knol, Anne-Chantal [1 ]
Nguyen, Jean-Michel [3 ]
Khammari, Amir [1 ,2 ]
Dreno, Brigitte [1 ,2 ]
机构
[1] CHU Hotel Dieu, Immunodermatol Lab, F-44093 Nantes 1, France
[2] CHU Hotel Dieu, Oncodermatol Unit, CIC Biotherapie INSERM 0503, F-44093 Nantes 1, France
[3] CHU Nantes, Epidemiol & Biostat Dept, F-44093 Nantes 1, France
关键词
innate immunity; melanoma; toll-like receptors; TOLL-LIKE RECEPTORS; TUMOR-INFILTRATING LYMPHOCYTES; STAGE-III MELANOMA; METASTATIC MELANOMA; TOPICAL IMIQUIMOD; ADOPTIVE TRANSFER; ADJUVANT THERAPY; CANCER-THERAPY; IN-VITRO; IMMUNITY;
D O I
10.1684/ejd.2011.1526
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
There is increasing evidence that melanoma cells express TLR2, -3, and -4. However, the expression of other TLRs by these cells still remains unknown. We investigated the expression patterns of TLR2, -3, -4, -7, -8 and -9 both on melanoma-invaded lymph nodes and on melanoma cell lines. TLR2, -3, -4, -7 and -9mRNA expression was determined by quantitative RT-PCR. The TLR protein expression level was measured ex vivo by immunohistochemistry and in vitro by flow cytometry. Results: At the mRNA level, melanoma cells in vitro, and possibly ex vivo, expressed TLR2, -3, -4, -7 and -9. TLR2 and -4 protein expressions ex vivo were over 50%, contrasting with an absence of these 2 TLRs in vitro. On the contrary, TLR-3 and -8 proteins had a low expression ex vivo with a high expression in vitro. TLR-7 and -9 proteins were expressed ex vivo and in vitro. Our study demonstrates for the first time that melanoma cells express TLR7 and -8.
引用
收藏
页码:899 / 905
页数:7
相关论文
共 25 条
[11]   The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors [J].
Kawai, Taro ;
Akira, Shizuo .
NATURE IMMUNOLOGY, 2010, 11 (05) :373-384
[12]   Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma [J].
Khammari, Amir ;
Nguyen, Jean-Michel ;
Pandolfino, Marie Christine ;
Quereux, Gaelle ;
Brocard, Anabelle ;
Bercegeay, Sylvain ;
Cassidanius, Alain ;
Lemarre, Philippe ;
Volteau, Christelle ;
Labarriere, Nathalie ;
Jotereau, Francine ;
Dreno, Brigitte .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (11) :1853-1860
[13]   Toll-like receptor 9 (TLR9) agonists in the treatment of cancer [J].
Krieg, A. M. .
ONCOGENE, 2008, 27 (02) :161-167
[14]   Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients [J].
Labarrière, N ;
Pandolfino, MC ;
Gervois, N ;
Khammari, A ;
Tessier, MH ;
Dréno, B ;
Jotereau, F .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (10) :532-538
[15]   Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4 [J].
Molteni, M ;
Marabella, D ;
Orlandi, C ;
Rossetti, C .
CANCER LETTERS, 2006, 235 (01) :75-83
[16]   Toll-like receptors and acquired immunity [J].
Pasare, C ;
Medzhitov, R .
SEMINARS IN IMMUNOLOGY, 2004, 16 (01) :23-26
[17]   Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells [J].
Pasare, C ;
Medzhitov, R .
SCIENCE, 2003, 299 (5609) :1033-1036
[18]   A new mathematical model for relative quantification in real-time RT-PCR [J].
Pfaffl, MW .
NUCLEIC ACIDS RESEARCH, 2001, 29 (09) :E45
[19]  
Rigel DS, 2010, ARCH DERMATOL, V146, P318, DOI 10.1001/archdermatol.2009.379
[20]   A family of human receptors structurally related to Drosophila Toll [J].
Rock, FL ;
Hardiman, G ;
Timans, JC ;
Kastelein, RA ;
Bazan, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :588-593